Francesco Giallauria
Overview
Explore the profile of Francesco Giallauria including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
167
Citations
2553
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Visco V, Forte M, Giallauria F, DAmbrosio L, Piccoli M, Schiattarella G, et al.
Int J Cardiol
. 2025 Mar;
:133166.
PMID: 40088953
The benefits of cardiac rehabilitation (CR) have been demonstrated in patients after myocardial infarction (MI), and in patients with chronic heart failure (HF). The core components of the CR program...
2.
Mattina A, Giammanco A, Noto D, Geraci G, Nardi E, Barbagallo C, et al.
J Clin Med
. 2025 Feb;
14(4).
PMID: 40004776
Familial hypercholesterolemia (FH) is a genetic disorder characterized by high plasma levels of low-density lipoprotein cholesterol (LDL-C) and exposing patients to higher risk of early cardiovascular (CV) atherosclerotic diseases. Though...
3.
Testa C, Salvi M, Zucchini I, Cattabiani C, Giallauria F, Petraglia L, et al.
Int J Environ Res Public Health
. 2025 Feb;
22(2).
PMID: 40003404
Atrial Fibrillation can be considered a geriatric syndrome for its prevalence and incidence, its impact on patients' quality of life, and Health Systems' economy. The European Society of Cardiology 2024...
4.
Faggiano A, Gualeni A, Barbieri L, Mureddu G, Venturini E, Giallauria F, et al.
J Clin Med
. 2025 Jan;
14(2).
PMID: 39860503
This study assessed the proportion of secondary cardiovascular prevention patients who achieved low-density lipoprotein (LDL) cholesterol targets as per the 2019 ESC/EAS Dyslipidemia Guidelines. We also evaluated whether lipid-lowering therapies...
5.
Gargiulo P, Marzano F, Crisci M, Marcucci R, Bruzzese D, Maloberti A, et al.
J Am Coll Cardiol
. 2024 Dec;
85(5):536-540.
PMID: 39665700
No abstract available.
6.
Ambrosetti M, Fattirolli F, Gnerre P, Mastroianni F, Mureddu G, Dentali F, et al.
Int J Cardiol Cardiovasc Risk Prev
. 2024 Aug;
21:200275.
PMID: 39118993
The Italian Association for Cardiovascular Rehabilitation and Prevention (ITACARE-P) and the Italian Federation of Associations of Hospital Doctors on Internal Medicine (FADOI) released a joint position paper to guide referrals...
7.
Cuomo G, Di Lorenzo A, Tramontano A, Iannone F, DAngelo A, Pezzella R, et al.
Rev Cardiovasc Med
. 2024 Jul;
23(4):144.
PMID: 39076241
Heart failure (HF) is a chronic, progressive, and inexorable syndrome affecting worldwide billion of patients (equally distributed among men and women), with prevalence estimate of 1-3% in developed countries. HF...
8.
Ruzzolini M, Giallauria F, Fattirolli F, Venturini E, Maranta F, Mureddu G, et al.
Int J Cardiol Cardiovasc Risk Prev
. 2024 Jun;
21:200284.
PMID: 38846680
No abstract available.
9.
Giallauria F, Napoli R
Eur J Prev Cardiol
. 2024 Jun;
31(16):1958-1959.
PMID: 38824423
No abstract available.
10.
Lauretani F, Giallauria F, Testa C, Zinni C, Lorenzi B, Zucchini I, et al.
Int J Mol Sci
. 2024 May;
25(10).
PMID: 38791331
Dopamine is a key neurotransmitter involved in physiological processes such as motor control, motivation, reward, cognitive function, and maternal and reproductive behaviors. Therefore, dysfunctions of the dopaminergic system are related...